Classification
- Anatomical main groupBBlood and blood-forming organs
- Therapeutic subgroupB05
- Pharmacological subgroupB05A
- Chemical subgroupB05AABlood substitutes and plasma protein fractions
- Chemical substanceB05AA05
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 28 registrations
- Advanced Relief Eye Drops0.1 % / W/V + 1 % / W/V + 1 % / W/V + 0.05 % / W/V · Solution · Juno OTC INC
- LMD 10% in 0.9% Sodium Chloride10 % + 0.9 % · Solution · Pfizer Canada Ulc
- LMD 10% in Dextrose 5%10 % + 5 % · Solution · Pfizer Canada Ulc
- Tears Naturale Forte0.1 % + 0.2 % + 0.3 % · Solution · Alcon Canada INC
Brazil
Anvisa · 20 registrations
At a glance
- ATC code
- B05AA05
- ATC group
- Blood and blood-forming organs
- Registers
- 6
- Historical lists
- 2
- Registrations
- 80
- With their own page
- 15
- Companies
- 39
All medicines with Dextran
Human medicines from every register that match Dextran by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
98 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Dextran 40 5% in Dextrose | Saudi Arabia | Authorised | B. Braun | ||
| Dextran 70 6% in Dextrose | Saudi Arabia | Authorised | B. Braun | ||
| Dextran 40 10% in Dextrose | Saudi Arabia | Authorised | B. Braun | ||
| Dextran-40 in 5% Dextrose InjCombination | Saudi Arabia | Authorised | Pharmaceutical Solution Industries (PSI) | ||
| Dextran-40 in N.SalineCombination | Saudi Arabia | Authorised | Pharmaceutical Solution Industries (PSI) | ||
| Dextran 70 6% in 0.9% NaclCombination | Saudi Arabia | Authorised | McGAW | ||
| Dextran-70 6% in N.Saline InfCombination | Saudi Arabia | Authorised | Pharmaceutical Solution Industries (PSI) | ||
| Dextran-70 6% in N.Saline InfCombination | Saudi Arabia | Authorised | Pharmaceutical Solution Industries (PSI) | ||
| DEXTRAN-70 6% IN DEXTROSE 5% Infusion*Combination | Saudi Arabia | Authorised | Pharmaceutical Solution Industries (PSI) | ||
| Dextran 40 5% in Normal Saline | Saudi Arabia | Authorised | B. Braun | ||
| Dextran 70 6% in Normal Saline | Saudi Arabia | Authorised | B. Braun | ||
| Dextran 40 10% in Normal Saline | Saudi Arabia | Authorised | B. Braun | ||
| Dextran 40 10% in Normal Saline | Saudi Arabia | Authorised | Kuwait Saudi Pharmaceutical Industries | ||
| Iron Dextran | United States | 50MG IRON/ML | injectable | Not marketed | Sanofi Aventis US |
| LMD 10% in Dextrose 5%Combination | Canada | 10 % + 5 % | Solution | Marketed | Pfizer Canada Ulc |
| Photrexa Viscous in Dextran 20% | United States | 5'-PHOSPHATE 0.146% | solution/drops | Marketed | Glaukos |
| Photrexa Viscous in Dextran 20%/Photrexa | United States | 5'-PHOSPHATE SODIUM EQ 0.146% BASE/ML | solution/drops | Marketed | Glaukos |
| Dex-70-Tec | Brazil | Authorised | Comissao Nacional de Energia Nuclear | ||
| Dex-500-Tec | Brazil | Authorised | Comissao Nacional de Energia Nuclear | ||
| DURATEARS, oogdruppelsCombination | Netherlands | Oogdruppels, oplossing | Authorised | Alcon Nederland B.V. | |
| Advanced Relief Eye DropsCombination | Canada | 0.1 % / W/V + 1 % / W/V + 1 % / W/V + 0.05 % / W/V | Solution | Marketed | Juno OTC INC |
| LMD 10% in 0.9% Sodium ChlorideCombination | Canada | 10 % + 0.9 % | Solution | Marketed | Pfizer Canada Ulc |
| Tears Naturale ForteCombination | Canada | 0.1 % + 0.2 % + 0.3 % | Solution | Marketed | Alcon Canada INC |
| Tears Naturale FreeCombination | Canada | 0.1 % / W/V + 0.3 % / W/V | Drops | Marketed | Alcon Canada INC |
| Tears Naturale IICombination | Canada | 0.1 % / W/V + 0.3 % / W/V | Drops | Marketed | Alcon Canada INC |



